• Our Services
    • The Information Commons
    • Shifting the Research Paradigm
    • The Cancer Commons Difference
    • Our Approach
  • About Your Cancer
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Diffuse Midline Glioma
    • Esophageal Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Cancer
  • About Us
    • Our Story
    • Facing Advanced Cancer
    • Meet the Team that Cares
    • Distinguished Advisors
    • Our Partners
    • Support Our Services
    • Talk to Us
    • Financial Documents
  • Testimonials
    • All Testimonials
  • Support Us
    • Many Ways to Give
    • What Your Support Makes Possible
  • Our Services
    • The Information Commons
    • Shifting the Research Paradigm
    • The Cancer Commons Difference
    • Our Approach
  • About Your Cancer
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Diffuse Midline Glioma
    • Esophageal Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Cancer
  • About Us
    • Our Story
    • Facing Advanced Cancer
    • Meet the Team that Cares
    • Distinguished Advisors
    • Our Partners
    • Support Our Services
    • Talk to Us
    • Financial Documents
  • Testimonials
    • All Testimonials
  • Support Us
    • Many Ways to Give
    • What Your Support Makes Possible
 

Chronic Myelomonocytic Leukemia: 2022 Update on Diagnosis, Risk Stratification, and Management

July 13, 2022
Focus: Leukemia
Topics: Treatment Options

Written for oncology healthcare professionals, this article from the American Journal of Hematology covers the best new therapies for chronic myelomonocytic leukemia in 2022.

.

Tags: 5-azacitidine, chronic myelomonocytic leukemia, decitabine, stem cell transplant, TET2

Our Mission: Cancer Commons is a non-profit network of patients, physicians, and scientists united by a shared goal—to optimize each patient’s outcome and maximize collective learning to benefit the next patient.

Don’t miss Cancer Commons Connects
Exclusive monthly insights and stories—from and for our community

Working.

Our Services

  • Care Navigation
  • Personalized Action Plans
  • Registering with Cancer Commons
  • Frequently Asked Questions (FAQ)

Perspectives

  • Latest Research
  • Treatment Options
  • Molecular Testing
  • Navigating Treatment
  • Living with Cancer
  • Patient Stories
  • Curious Dr. George
  • The Big Picture
  • Peer-Reviewed Publications

Organization

  • Our Story
  • Our Team
  • Our Core Values
  • Board of Directors
  • Partners
  • Expert Physician Advisors
  • Careers

About Us

  • News and Events
  • Financial Documents
  • Contact Us

Support & Giving

  • Contribute Now
  • Many Ways to Give
  • What Your Support Makes Possible
  • Testimonials


Donate

Cancer Commons
2625 Middlefield Road Suite 104
Palo Alto, CA 94306

650-289-4044

Patient Hotline

877-971-1200

  • Privacy Policy

© 2024 Cancer Commons.